Midkine expression in oral squamous cell carcinoma and leukoplakia

Journal of Oral Pathology and Medicine

Volumn 41, Issue 1, 2012, Pages 21-26

  Jham, Bruno Correia ^a   Costa, Nadia Lago ^a   Silva, Janine Mayra ^b   de Miranda, Alessandra Castro ^b   Oliveira, Jose Carlos ^c   Silva, Tarcília Aparecida ^b   Batista, Aline Carvalho ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Araujo Jorge Hospital   (Brazil)

Author keywords

Leukoplakia; Midkine; Oral cancer; Oral squamous cell carcinoma

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN; MIDKINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOPLAKIA; LYMPH NODE METASTASIS; MALE; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ANTIGENS, CD31; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855462086     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01049.x     Document Type: Article

References (22)

1. Greenlee RT, Hill-Harmon MB, Murray T. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15-36.
2. Jemal A, Sieger R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
3. Ruan M, Ji T, Wu Z, Zhou J, Zhang C. Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis. Int J Oral Maxillofac Surg 2007; 36: 159-64.
4. Kadomatsu K, Muramatsu T. Midikine and pleiotrophin in neural development and cancer. Cancer Lett 2004; 204: 127-43.
5. Kurtz A, Schult AM, Wellstein A. Pleiotropin and midkine in normal development and tumor biology. Crit Rev Oncog 1995; 6: 151-77.
6. Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988; 151: 1312-8.
7. Tong Y, Mentlein R, Buhl R, et al. Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas. J Neurochem 2007; 100: 1097-107.
8. Ota K, Fujimori H, Ueda M, et al. Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma. Int J Oncol 2010; 37: 797-804.
9. Owada K, Sanjo N, Kobayashi T, et al. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 1999; 73: 2084-92.
10. Muramatsu H, Muramatsu T. Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors. Biochem Biophys Res Commun 1991; 177: 652-8.
11. Ota K, Fujimori M, Ueda M, et al. Midikine as a prognostic biomarker in oral squamous cell carcinoma. Br J Cancer 2008; 99: 655-62.
12. Pindborg JJ, Reichard PA, Smith CJ, Van Der Wall I. Histological Typing of Cancer and Precancer of the Oral Mucosa. World Health Organization Classification of Tumours. Berlin: Springer-Verlag, 1997; 21-31.
13. Aridome K, Tsutsui J, Takao S, et al. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 1995; 86: 655-61.
14. Garver RI, Radford DM, Donis-Keller H, Wick MR, Milner PG. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994; 74: 1584-90.
15. Garver RI, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 1993; 9: 463-6.
16. Tsutsui J, Kadomatsu K, Matsubara S, et al. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilm′s tumour and other human carcinomas. Cancer Res 1993; 53: 1281-5.
17. Ren YJ, Zhang QY. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12: 2006-10.
18. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-10.
19. Speight PM, Morgan PR. The natural history and pathology of oral cancer and precancer. Community Dent Health 1993; 10: 31-41.
20. Ye C, Qi M, Fan QW, et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer 1999; 79: 179-84.
21. Macluskey M, Chandrachud LM, Pazouki S, et al. Apoptosis, proliferation, and angiogenesis in oral tissues. Possible relevance to tumour progression. J Pathol 2000; 191: 368-75.
22. Leibowitz B, Yu J. Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 2010; 9: 417-22.